CD40 and systemic lupus erythematosus: Similarly, genetically engineered cellular nanovesicles bearing CD40 were found to effectively inhibit the immune response in mouse models of systemic lupus erythematosus and especially deliver a mycophenolate load by achieving an enhanced outcome [94].